MedPath

Sarcopenia and Nutritional Status in a Rehabilitation Setting

Recruiting
Conditions
Sarcopenia
Interventions
Diagnostic Test: handgrip strenght
Diagnostic Test: Bioelectrical Impedance Analysis (BIA)
Diagnostic Test: MUST
Diagnostic Test: GLIM
Biological: Gut microbiota
Biological: Blood Sample
Other: Anthropometric measures
Registration Number
NCT04791540
Lead Sponsor
Fondazione Don Carlo Gnocchi Onlus
Brief Summary

In this pilot observational study the primary outcome is to assess, in a Respiratory Rehabilitation Unit, if there is an association between sarcopenia, assessed by handgrip strenght and BIA, and a delayed decannulation time in patients who underwent tracheostomy.

Secondary outcomes are to assess if there is an association between an increased malnutrition risk (assessed by MUST), a poor nutritional status (assessed by GLIM criteria) and a delayed decannulation time and the gut microbiota composition.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Signed informed consent from patients or legal guardians for patients unfit to plead
  • Presence of tracheostomy at admission
Exclusion Criteria
  • Refusal
  • Pregnancy
  • Pace maker/implantable cardioverter
  • No legal guardians for patients unfit to plead

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with trachestomyhandgrip strenghtPatients, attending a respiratory rehabilitation program, who underwent tracheostomy decannulation
Patients with trachestomyBioelectrical Impedance Analysis (BIA)Patients, attending a respiratory rehabilitation program, who underwent tracheostomy decannulation
Patients with trachestomyGLIMPatients, attending a respiratory rehabilitation program, who underwent tracheostomy decannulation
Patients with trachestomyGut microbiotaPatients, attending a respiratory rehabilitation program, who underwent tracheostomy decannulation
Patients with trachestomyAnthropometric measuresPatients, attending a respiratory rehabilitation program, who underwent tracheostomy decannulation
Patients with trachestomyMUSTPatients, attending a respiratory rehabilitation program, who underwent tracheostomy decannulation
Patients with trachestomyBlood SamplePatients, attending a respiratory rehabilitation program, who underwent tracheostomy decannulation
Primary Outcome Measures
NameTimeMethod
Change from admission in muscle mass at decannulation timeRespiratory Rehabilitation Unit admission (T0) and decannulation time (T1), an average of 10 days

Measurement of muscle mass with Bioelectrical Impedance Analysis (BIA).

Change from admission in hangrip strenght at decannulation timeRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Measurement of handgrip strenght with a handheld dynamometer. Male cut-off: \<27 Kg Female cut-off: \<16 Kg

Secondary Outcome Measures
NameTimeMethod
CreatinineRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in creatinine at decannulation time

AlbuminRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in albumin at decannulation time

Vitamin (25OH) DRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in vitamin (25OH) D at decannulation time

SeleniumRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in selenium at decannulation time

Growth Hormone (GH)Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in growth hormone at decannulation time

LeptinRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in leptin at decannulation time

Tumor Necrosis Factor-α (TNF-α)Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in Tumor Necrosis Factor-α (TNF-α) at decannulation time

Uric AcidRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in uric acid at decannulation time

MagnesiumRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in magnesium at decannulation time

Change from admission in Malnutrition Universal Screening Tool (MUST) score at decannulation timeRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

MUST is a screening tool to identify adults who are malnourished, at risk of malnutrition or obese.

score 0: low risk score 1: medium risk score 2 or more: high risk

Change from admission in nutritional status at decannulation timeRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Global Leadership Initiative on Malnutrition (GLIM) criteria are 5 diagnostic criteria to assess malnutrition that include 3 phenotypic (weight loss, low body mass index and reduced muscle mass) and 2 etiologic (reduced food intake/assimilation, and inflammation/disease burden) criteria.

To diagnose malnutrition at least 1 phenotypic criterion and 1 etiologic criterion should be present.

Creatine PoshokinaseRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in creatine poshokinase at decannulation time

Pro-inflammatory cytokine interleukin IL-6Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in pro-inflammatory cytokine interleukinIL-6 at decannulation time

Insuline-like Growth Factor-1 (IGF-1)Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in Insuline-like Growth Factor-1 (IGF-1) at decannulation time

Dehydroepiandrosterone (DHEA)Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in dehydroepiandrosterone (DHEA) at decannulation time

TestosteroneRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in testosterone at decannulation time

Change from admission in Body Mass Index (BMI) score at decannulation timeRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Measurement of height and weight to get a BMI score (weight/(height\^2). BMI \<18.5 Kg/m\^2: underweight BMI 18.5-24.9 Kg/m\^2: normal range BMI 25.0-29.9 Kg/m\^2: overweight BMI 30.0-34.9 Kg/m\^2 obese class I BMI 35.0-39.9 Kg/m\^2 obese class II BMI \>= 40 Kg/m\^2 obese class III

Change from admission in Gut Microbiota (GM) composition at decannulation timeRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Gut Microbiota (GM) composition

Protein C reactive (PCR)Respiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in Protein C reactive (PCR) at decannulation time

Lymphocyte countRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in lymphocyte count at decannulation time

Total serum proteinRespiratory Rehabiliation Unit admission (T0) and decannulation time (T1), an average of 10 days

Change from admission in total serum protein at decannulation time

Trial Locations

Locations (1)

Fondazione Don Carlo Gnocchi

🇮🇹

Firenze, Italy

© Copyright 2025. All Rights Reserved by MedPath